Abelardo N S, Ramos E F, Mendoza V L, Sulit Y Q, Mitchell M J
Cardiovascular Section, University of the Phillippines, Philippine General Hospital, Manila.
J Hum Hypertens. 1989 Feb;3(1):57-9.
We conducted a randomised double-blind crossover comparison of felodipine, 10 mg once daily, nifedipine 20 mg twice daily, each treatment being given as a monotherapy for four weeks. Active treatment was preceded by a two-week placebo run-in. Both systolic (SBP) and diastolic (DBP) blood pressures (supine and erect) fell significantly (all P less than 0.001) following both drug treatments. Nifedipine produced a greater orthostatic effect, and hence a significantly greater fall in erect SBP than felodipine (P less than 0.05). There was no significant difference between the effects of the drugs on DBP. Achieved DBP was 90 mmHg or less in 18/22 patients on felodipine and 18/22 patients on nifedipine. Both drugs were well-tolerated. Felodipine given once daily was effective as a monotherapy for the control of mild to moderate hypertension and compared favourably with twice daily nifedipine.
我们进行了一项随机双盲交叉对照试验,比较每日一次服用10毫克非洛地平与每日两次服用20毫克硝苯地平的疗效,每种治疗方法均作为单一疗法使用四周。在进行积极治疗之前,先有为期两周的安慰剂导入期。两种药物治疗后,收缩压(SBP)和舒张压(DBP)(仰卧位和直立位)均显著下降(所有P值均小于0.001)。硝苯地平产生的体位性效应更大,因此直立位SBP的下降幅度显著大于非洛地平(P小于0.05)。两种药物对DBP的影响无显著差异。服用非洛地平的22例患者中有18例、服用硝苯地平的22例患者中有18例的舒张压降至90 mmHg或更低。两种药物耐受性均良好。每日一次服用非洛地平作为单一疗法对控制轻度至中度高血压有效,且与每日两次服用硝苯地平相比效果良好。